Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks.
Alberts DS, et al. Among authors: hess lm.
J Natl Cancer Inst. 2005 Jun 1;97(11):846-53. doi: 10.1093/jnci/dji144.
J Natl Cancer Inst. 2005.
PMID: 15928305
Clinical Trial.